Ozonation of carbamazepine, diclofenac, sulfamethoxazole and trimethoprim and formation of major oxidation products

References

• Y. Luo, W. Guo, H.H. Ngo, L.D. Nghiem, F.I. Hai, J. Zhang, S. Liang, X.C. Wang, A review on the occurrence of micropollutants in the aquatic environment and their fate and removal during wastewater treatment, Sci. Total Environ. 473–474 (2014) 619–641.10.1016/j.scitotenv.2013.12.065
   PubMed Web of Science ®Google Scholar
• B. Halling-Sørensen, S. Nors Nielsen, P.F. Lanzky, F. Ingerslev, H.C. Holten Lützhøft, S.E. Jørgensen, Occurrence, fate and effects of pharmaceutical substances in the environment—A review, Chemosphere 36 (1998) 357–393.10.1016/S0045-6535(97)00354-8
   PubMed Web of Science ®Google Scholar
• T.A. Ternes, Occurrence of drugs in German sewage treatment plants and rivers, Water Res. 32 (1998) 3245–3260.10.1016/S0043-1354(98)00099-2
   Web of Science ®Google Scholar
• T.A. Ternes, M. Stumpf, J. Mueller, K. Haberer, R.D. Wilken, M. Servos, Behavior and occurrence of estrogens in municipal sewage treatment plants—I. Investigations in Germany, Canada and Brazil, Sci. Total Environ. 225 (1999) 81–90.10.1016/S0048-9697(98)00334-9
   PubMed Web of Science ®Google Scholar
• G.R. Boyd, H. Reemtsma, D.A. Grimm, S. Mitra, Pharmaceuticals and personal care products (PPCPs) in surface and treated waters of Louisiana, USA and Ontario, Canada, Sci. Total Environ. 311 (2003) 135–149.10.1016/S0048-9697(03)00138-4
   PubMed Web of Science ®Google Scholar
• T. Heberer, Occurrence, fate, and removal of pharmaceutical residues in the aquatic environment: A review of recent research data, Toxicol. Lett. 131 (2002) 5–17.10.1016/S0378-4274(02)00041-3
   PubMed Web of Science ®Google Scholar
• F. Sacher, F.T. Lange, H.J. Brauch, I. Blankenhorn, Pharmaceuticals in groundwaters, J. Chromatogr. A 938 (2001) 199–210.10.1016/S0021-9673(01)01266-3
   PubMed Web of Science ®Google Scholar
• B. Soulet, A. Tauxe, J. Tarradellas, Analysis of acidic drugs in swiss wastewaters, Int. J. Environ. Anal. Chem. 82 (2002) 659–667.10.1080/0306731021000075384
   Web of Science ®Google Scholar
• X.S. Miao, F. Bishay, M. Chen, C.D. Metcalfe, Occurrence of antimicrobials in the final effluents of wastewater treatment plants in Canada, Environ. Sci. Technol. 38 (2004) 3533–3541.10.1021/es030653q
   PubMed Web of Science ®Google Scholar
• L.D. Arcand-Hoy, A.C. Nimrod, W.H. Benson, Endocrine-modulating substances in the environment: Estrogenic effects of pharmaceutical products, Int. J. Toxicol. 17 (1998) 139–158.10.1080/109158198226675
   Web of Science ®Google Scholar
• J.P. Sumpter, Xenoendocrine disrupters—Environmental impacts, Toxicol. Lett. 102–103 (1998) 337–342.10.1016/S0378-4274(98)00328-2
   PubMed Web of Science ®Google Scholar
• K. Kummerer, Resistance in the environment, J. Antimicrob. Chemother. 54 (2004) 311–320.10.1093/jac/dkh325
   PubMed Web of Science ®Google Scholar
• M. Petrovic, S. Gonzalez, D. Barceló, Analysis and removal of emerging contaminants in wastewater and drinking water, TrAC Trends Anal. Chem. 22 (2003) 685–696.10.1016/S0165-9936(03)01105-1
   Web of Science ®Google Scholar
• J.L. Oaks, M. Gilbert, M.Z. Virani, R.T. Watson, C.U. Meteyer, B.A. Rideout, H.L. Shivaprasad, S. Ahmed, M.J. Iqbal Chaudhry, M. Arshad, S. Mahmood, A. Ali, A. Ahmed Khan, Diclofenac residues as the cause of vulture population decline in Pakistan, Nature 427 (2004) 630–633.10.1038/nature02317
   PubMed Web of Science ®Google Scholar
• R. Triebskorn, H. Casper, A. Heyd, R. Eikemper, H.R. Köhler, J. Schwaiger, Toxic effects of the non-steroidal anti-inflammatory drug diclofenac, Aquat. Toxicol. 68 (2004) 151–166.10.1016/j.aquatox.2004.03.015
   PubMed Web of Science ®Google Scholar
• B. Ferrari, N. Paxéus, R.L. Giudice, A. Pollio, J. Garric, Ecotoxicological impact of pharmaceuticals found in treated wastewaters: Study of carbamazepine, clofibric acid, and diclofenac, Ecotoxicol. Environ. Saf. 55 (2003) 359–370.10.1016/S0147-6513(02)00082-9
   PubMed Web of Science ®Google Scholar
• Z.-H. Li, V. Zlabek, J. Velisek, R. Grabic, J. Machova, J. Kolarova, P. Li, T. Randak, Acute toxicity of carbamazepine to juvenile rainbow trout (Oncorhynchus mykiss): Effects on antioxidant responses, hematological parameters and hepatic EROD, Ecotoxicol. Environ. Saf. 74 (2011) 319–327.10.1016/j.ecoenv.2010.09.008
   PubMed Web of Science ®Google Scholar
• K. Kümmerer, Drugs in the environment: Emission of drugs, diagnostic aids and disinfectants into wastewater by hospitals in relation to other sources—A review, Chemosphere 45 (2001) 957–969.10.1016/S0045-6535(01)00144-8
   PubMed Web of Science ®Google Scholar
• P.E. Stackelberg, E.T. Furlong, M.T. Meyer, S.D. Zaugg, A.K. Henderson, D.B. Reissman, Persistence of pharmaceutical compounds and other organic wastewater contaminants in a conventional drinking-water-treatment plant, Sci. Total Environ. 329 (2004) 99–113.10.1016/j.scitotenv.2004.03.015
   PubMed Web of Science ®Google Scholar
• D. Vogel, A. Simon, A.A. Alturki, B. Bilitewski, W.E. Price, L.D. Nghiem, Effects of fouling and scaling on the retention of trace organic contaminants by a nanofiltration membrane: The role of cake-enhanced concentration polarisation, Sep. Purif. Technol. 73 (2010) 256–263.10.1016/j.seppur.2010.04.010
   Web of Science ®Google Scholar
• L.D. Nghiem, A.I. Schäfer, Adsorption and transport of trace contaminant estrone in NF/RO membranes, Environ. Eng. Sci. 19 (2002) 441–451.10.1089/109287502320963427
   Web of Science ®Google Scholar
• K.O. Agenson, J.-I. Oh, T. Urase, Retention of a wide variety of organic pollutants by different nanofiltration/reverse osmosis membranes: Controlling parameters of process, J. Membr. Sci. 225 (2003) 91–103.10.1016/j.memsci.2003.08.006
   Web of Science ®Google Scholar
• J. Staehelin, J. Hoigne, Decomposition of ozone in water in the presence of organic solutes acting as promoters and inhibitors of radical chain reactions, Environ. Sci. Technol. 19 (1985) 1206–1213.10.1021/es00142a012
   PubMed Web of Science ®Google Scholar
• T. Kosjek, E. Heath, Applications of mass spectrometry to identifying pharmaceutical transformation products in water treatment, TrAC Trends Anal. Chem. 27 (2008) 807–820.10.1016/j.trac.2008.08.014
   Web of Science ®Google Scholar
• P. Nebout, B. Cagnon, S. Delpeux, A. Di Giusto, O. Chedeville, Comparison of the efficiency of adsorption, ozonation, and ozone/activated carbon coupling for the removal of pharmaceuticals from water, J. Environ. Eng. (Reston, VA, U. S.) 142 (2016), doi: 10.1061/(ASCE)EE.1943-7870.0001042.
   Google Scholar
• R.C. Martins, R.F. Dantas, C. Sans, S. Esplugas, R.M. Quinta-Ferreira, Ozone/H2O2 performance on the degradation of sulfamethoxazole, Ozone: Sci. Eng. 37 (2015) 509–517.10.1080/01919512.2015.1053427
   Web of Science ®Google Scholar
• A.R. Ribeiro, O.C. Nunes, M.F.R. Pereira, A.M.T. Silva, An overview on the advanced oxidation processes applied for the treatment of water pollutants defined in the recently launched Directive 2013/39/EU, Environ. Int. 75 (2015) 33–51.10.1016/j.envint.2014.10.027
   PubMed Web of Science ®Google Scholar
• N. Facile, B. Barbeau, M. Prévost, B. Koudjonou, Evaluating bacterial aerobic spores as a surrogate for Giardia and Cryptosporidium inactivation by ozone, Water Res. 34 (2000) 3238–3246.10.1016/S0043-1354(00)00086-5
   Web of Science ®Google Scholar
• D.C. McDowell, M.M. Huber, M. Wagner, U. von Gunten, T.A. Ternes, Ozonation of carbamazepine in drinking water: Identification and kinetic study of major oxidation products, Environ. Sci. Technol. 39 (2005) 8014–8022.10.1021/es050043l
   PubMed Web of Science ®Google Scholar
• C. Zwiener, Occurrence and analysis of pharmaceuticals and their transformation products in drinking water treatment, Anal. Bioanal. Chem. 387 (2007) 1159–1162.10.1007/s00216-006-0818-2
   PubMed Web of Science ®Google Scholar
• T.A. Ternes, M. Meisenheimer, D. McDowell, F. Sacher, H.J. Brauch, B. Haist-Gulde, G. Preuss, U. Wilme, N. Zulei-Seibert, Removal of pharmaceuticals during drinking water treatment, Environ. Sci. Technol. 36 (2002) 3855–3863.10.1021/es015757k
   PubMed Web of Science ®Google Scholar
• T.A. Ternes, J. Stüber, N. Herrmann, D. McDowell, A. Ried, M. Kampmann, B. Teiser, Ozonation: A tool for removal of pharmaceuticals, contrast media and musk fragrances from wastewater? Water Res. 37 (2003) 1976–1982.10.1016/S0043-1354(02)00570-5
   PubMed Web of Science ®Google Scholar
• C. Zwiener, F.H. Frimmel, Oxidative treatment of pharmaceuticals in water, Water Res. 34 (2000) 1881–1885.10.1016/S0043-1354(99)00338-3
   Web of Science ®Google Scholar
• M.M. Huber, S. Canonica, G.Y. Park, U. von Gunten, Oxidation of pharmaceuticals during ozonation and advanced oxidation processes, Environ. Sci. Technol. 37 (2003) 1016–1024.10.1021/es025896h
   PubMed Web of Science ®Google Scholar
• S. Gao, Z. Zhao, Y. Xu, J. Tian, H. Qi, W. Lin, F. Cui, Oxidation of sulfamethoxazole (SMX) by chlorine, ozone and permanganate—A comparative study, J. Hazard. Mater. 274 (2014) 258–269.10.1016/j.jhazmat.2014.04.024
   PubMed Web of Science ®Google Scholar
• J. Kuang, J. Huang, B. Wang, Q. Cao, S. Deng, G. Yu, Ozonation of trimethoprim in aqueous solution: Identification of reaction products and their toxicity, Water Res. 47 (2013) 2863.10.1016/j.watres.2013.02.048
   PubMed Web of Science ®Google Scholar
• E. Donner, T. Kosjek, S. Qualmann, K.O. Kusk, E. Heath, D.M. Revitt, A. Ledin, H.R. Andersen, Ecotoxicity of carbamazepine and its UV photolysis transformation products, Sci. Total Environ. 443 (2013) 870–876.10.1016/j.scitotenv.2012.11.059
   PubMed Web of Science ®Google Scholar
• A. Rodayan, R. Roy, V. Yargeau, Oxidation products of sulfamethoxazole in ozonated secondary effluent, J. Hazard. Mater. 177 (2010) 237–243.10.1016/j.jhazmat.2009.12.023
   PubMed Web of Science ®Google Scholar
• U. Hübner, B. Seiwert, T. Reemtsma, M. Jekel, Ozonation products of carbamazepine and their removal from secondary effluents by soil aquifer treatment—Indications from column experiments, Water Res. 49 (2014) 34–43.10.1016/j.watres.2013.11.016
   PubMed Web of Science ®Google Scholar
• R.F. Dantas, S. Contreras, C. Sans, S. Esplugas, Sulfamethoxazole abatement by means of ozonation, J. Hazard. Mater. 150 (2008) 790–794.10.1016/j.jhazmat.2007.05.034
   PubMed Web of Science ®Google Scholar
• X. Liu, T. Garoma, Z. Chen, L. Wang, Y. Wu, SMX degradation by ozonation and UV radiation: A kinetic study, Chemosphere 87 (2012) 1134–1140.10.1016/j.chemosphere.2012.02.007
   PubMed Web of Science ®Google Scholar
• W.Q. Guo, R.L. Yin, X.J. Zhou, H.O. Cao, J.S. Chang, N.Q. Ren, Ultrasonic-assisted ozone oxidation process for sulfamethoxazole removal: Impact factors and degradation process, Desalin Water Treat. (2015) 1–8, doi: 10.1080/19443994.2015.1115373.
   Google Scholar
• V. Naddeo, C.S. Uyguner-Demirel, M. Prado, A. Cesaro, V. Belgiorno, F. Ballesteros, Enhanced ozonation of selected pharmaceutical compounds by sonolysis, Environ. Technol. 36 (2015) 1876–1883.10.1080/09593330.2015.1014864
   PubMed Web of Science ®Google Scholar
• T. Fujioka, Ozonation of N-nitrosamines in the reverse osmosis concentrate from water recycling applications, Ozone Sci. Eng. 36 174–180.
   Web of Science ®Google Scholar
• R. Criegee, Mechanismus der Ozonolyse (Mechanism of Ozonation), Angew. Chem. 87 (1975) 765–771.10.1002/(ISSN)1521-3757
   Google Scholar
• U. Hübner, U. von Gunten, M. Jekel, Evaluation of the persistence of transformation products from ozonation of trace organic compounds—A critical review, Water Res. 68 (2015) 150–170.10.1016/j.watres.2014.09.051
   PubMed Web of Science ®Google Scholar
• H. Yu, E. Nie, J. Xu, S. Yan, W.J. Cooper, W. Song, Degradation of diclofenac by advanced oxidation and reduction processes: Kinetic studies, degradation pathways and toxicity assessments, Water Res. 47 (2013) 1909–1918.
   PubMed Web of Science ®Google Scholar
• A.D. Coelho, C. Sans, A. Agüera, M.J. Gómez, S. Esplugas, M. Dezotti, Effects of ozone pre-treatment on diclofenac: Intermediates, biodegradability and toxicity assessment, Sci. Total Environ. 407 (2009) 3572–3578.10.1016/j.scitotenv.2009.01.013
   PubMed Web of Science ®Google Scholar
• R. Rosal, A. Rodríguez, J.A. Perdigón-Melón, M. Mezcua, M.D. Hernando, P. Letón, E. García-Calvo, A. Agüera, A.R. Fernández-Alba, Removal of pharmaceuticals and kinetics of mineralization by O3/H2O2 in a biotreated municipal wastewater, Water Res. 42 (2008) 3719–3728.10.1016/j.watres.2008.06.008
   PubMed Web of Science ®Google Scholar
• S. Othman, V. Mansuy-Mouries, C. Bensoussan, P. Battioni, D. Mansuy, Hydroxylation of diclofenac: An illustration of the complementary roles of biomimetic metalloporphyrin catalysts and yeasts expressing human cytochromes P450 in drug metabolism studies, C. R. Acad. Sci. 3 (2000) 751–755.
   Google Scholar
• D. Vogna, R. Marotta, A. Napolitano, R. Andreozzi, M. d’Ischia, Advanced oxidation of the pharmaceutical drug diclofenac with UV/H 2O2 and ozone, Water Res. 38 (2004) 414–422.10.1016/j.watres.2003.09.028
   PubMed Web of Science ®Google Scholar